Current role
Pamela Vig
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Pamela Vig
The proxy statement of Mirum Pharmaceuticals, Inc. reports total compensation of $1,507,496 for Pamela Vig in fiscal 2022, including a base salary of $450,000. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Mirum Pharmaceuticals, Inc. (MIRM)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Mirum Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher Peetz CEO
- Michael Grey CEO
- Eric Bjerkholt CFO
- Peter Radovich COO
- Lon Cardon, Ph.D., FMedSci Board Member
- Saira Ramasastry Board Member
- Timothy Walbert Board Member
- To approve Board Member
- William Fairey Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Mirum Pharmaceuticals, Inc. (MIRM) | Head of Research and Development | $450,000 | $1,507,496 |
| 2019 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Scientific Officer | $354,826 | $2,681,958 |
| 2018 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Scientific Officer | $27,500 | $27,500 |
Recent activity
No call appearances or filed executive changes recorded yet.